FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Sun Pharma Global Fze Alendronate Sodium Tablets Recall

Alendronate Sodium Tablets, USP, 70 mg*, 4-count blisters per carton, Rx only, Manufact…

Sun Pharma Global Fze · Sharm, N/A

Risk level
Class II
Reported by FDA
Mar 9, 2016
Recall ID
D-0735-2016
Check your lot numberHow we source this data

Summary

Sun Pharma Global Fze recalled Alendronate Sodium Tablets starting Feb 11, 2016. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0735-2016 on Mar 9, 2016. Reason: Failed Impurities/Degradation Specifications: Observed levels of highest unknown impurity exceeding specification limit at the 3 month stability time point. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specifications: Observed levels of highest unknown impurity exceeding specification limit at the 3 month stability time point.

Product description

Alendronate Sodium Tablets, USP, 70 mg*, 4-count blisters per carton, Rx only, Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol-389 350, Gujarat, India; Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512; NDC 41616-638-68, UPC 3 41616 63868 4.

Lot numbers, UPCs & expiration codes

Lot #s: JKP2234A, JKP2235A, Exp 04/17

Where it was sold

Nationwide and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0735-2016
Classification
Class II
Status
Terminated
Recall initiated
Feb 11, 2016
FDA report date
Mar 9, 2016
Quantity
381,120 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
Sun Pharma Global Fze

Original FDA data

Every field from FDA enforcement report D-0735-2016, exactly as published.

Show all FDA fields
City
Sharm
Status
Terminated
Country
United Arab Emirates
Event ID
73420
Address
Office # 43 Block Y Saif Zone
Code information
Lot #s: JKP2234A, JKP2235A, Exp 04/17
Report date
Mar 9, 2016
Product type
Drugs
Recall number
D-0735-2016
Classification
Class II
Recalling firm
Sun Pharma Global Fze
Product quantity
381,120 cartons
Termination date
May 23, 2017
Reason for recall
Failed Impurities/Degradation Specifications: Observed levels of highest unknown impurity exceeding specification limit at the 3 month stability time point.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Alendronate Sodium Tablets, USP, 70 mg*, 4-count blisters per carton, Rx only, Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol-389 350, Gujarat, India; Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512; NDC 41616-638-68, UPC 3 41616 63868 4.
Distribution pattern
Nationwide and Puerto Rico
Recall initiation date
Feb 11, 2016
Initial firm notification
E-Mail
Center classification date
Mar 3, 2016

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0735-2016, published Mar 9, 2016. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls